Colorectal Cancer

Campto (Irinotecan), Now Available In Seven Additional Countries

Published in Cancer Weekly, May 26th, 1997

Rhone-Poulenc Rorer Inc., Antony, France, announced that Campto (irinotecan), a new anticancer agent, is now available in seven additional countries including Austria, Finland, Luxembourg, Portugal, South Africa, Spain, and the United Kingdom.

Campto is indicated for the treatment of advanced metastatic colorectal cancer that has failed to respond to standard chemotherapy with 5-fluorouracil (5-FU) and folinic acid. Campto was also recently approved in Egypt. The drug has now been approved in 16 countries and is available in 10, including France (through RPR), Japan (through Yakult Honsha Co. Ltd.), and the United States (through Pharmacia & Upjohn).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry